INS and type 2 diabetes mellitus: The progressive resistance to insulin in T2DM patients could lead to pathological activation of the immune system, causing progressive impairment to microvascular and macrovascular tissue function, thus to increase the risk of cardiovascular events, kidney complications and mortality in patients (5, 6).